NewGenIVF reports 27.3M shares outstanding October 1

NewGenIVF Group Limited (NIVF) confirmed it had 27,287,002 issued and outstanding Class A ordinary shares at the close of business on October 1, 2026.

Rhea-AI Filing Summary

NewGenIVF Group Limited (NIVF) confirmed it had 27,287,002 issued and outstanding Class A ordinary shares at the close of business on October 1, 2026. The company said the count followed share issuances connected with a best efforts offering announced September 30, 2026, conversions of certain outstanding convertible promissory notes by certain holders, and share issuances under its equity line of credit facility.

Filing Explained

NewGenIVF Group Limited reports 27,287,002 Class A shares outstanding as of October 1, 2026, after issuances connected with the best-efforts offering announced September 30, 2026, convertible-note conversions and its equity line. Those additional share issuances increase the total share count and reduce existing holders’ percentage ownership, absent offsetting changes.

Key Figures

Issued and outstanding Class A ordinary shares: 27,287,002 shares

1 metrics

Issued and outstanding Class A ordinary shares 27,287,002 shares At the close of business on October 1, 2026

Key Terms

Class A ordinary shares, best efforts offering, convertible promissory notes, equity line of credit facility

4 terms

Class A ordinary shares financial

"total issued and outstanding class A ordinary shares"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

best efforts offering financial

"share issuances in connection with the best efforts offering"

convertible promissory notes financial

"conversion of certain outstanding convertible promissory notes"

A convertible promissory note is a loan a company takes that can later be turned into shares instead of being paid back in cash; think of lending money now in exchange for a voucher that can become ownership later. Investors care because it mixes credit risk and potential ownership upside—it can protect lenders if a company struggles while also diluting existing shareholders when converted, affecting future share value and investor returns.

equity line of credit facility financial

"share issuances pursuant to the Company’s equity line of credit facility"

An equity line of credit facility is a financing agreement that lets a company raise cash on demand by issuing new shares to a lender or investor as draws are made, similar to a credit card that’s paid by giving up a small portion of ownership instead of cash. It matters to investors because it provides flexible cash when needed but increases the number of shares outstanding, which can dilute existing ownership and affect the stock price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NIVF Class A ordinary shares were outstanding on October 1, 2026?

NewGenIVF Group Limited reported 27,287,002 issued and outstanding Class A ordinary shares at the close of business on October 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 06:30 AM Accepted by SEC EDGAR 10/05/2026 - 06:30 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File Number: 001-42004

NEWGENIVF GROUP LIMITED

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110 

Thailand

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒     Form 40-F ☐

EXPLANATORY NOTE

NewGenIVF Group Limited (the “Company”) confirms that as at the close of business on October 1, 2026, its total issued and outstanding class A ordinary shares (“Shares”) was 27,287,002 Shares, following share issuances in connection with the best efforts offering announced on September 30, 2026, the conversion of certain outstanding convertible promissory notes by certain convertible note holders, and shares issuances pursuant to the Company’s equity line of credit facility.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 5, 2026

	NewGenIvf Group Limited
	By:	/s/ Wing Fung Alfred Siu
	Name:	Wing Fung Alfred Siu
	Title:	Chairman of the Board and Director

2